The Union Health Ministry’s Directorate General of Health Services (DGHS) in its revised Covid-19 management guidelines, has dropped all medicines, except antipyretic and antitussive, for asymptomatic and mild COVID19 cases.
The DGHS has asked doctors to drop drugs like Hydroxychloroquine, Ivermectin, Doxycycline, Zinc, Multivitamins, etc. from prescription to treat asymptomatic or mildly symptomatic COVID19 patients.
In its May 27 order, the DGHS has advised the medical professionals to promote COVID-appropriate behaviour (mask, strict hand hygiene, physical distancing) among the coronavirus patients.
The guidelines advised people who experience Covid19 symptoms to seek tele-consultations and to consume a healthy balanced diet with proper hydration.
The patients and their families were asked to stay connected and engage in positive talks through phone, video-calls, etc.
“No medication required for COVID-19 infection. Continue medications for other co-morbid conditions, if any,” the guidelines said.
The DGHS said Remdesivir should be used only in select moderate/ severe hospitalised COVID19 patients on supplemental oxygen within 10 days of onset of disease.
“It is not indicated in mild coronavirus patients who are in home care/ COVID Care Centres. Physicians are advised to exercise extreme caution in using Remdesivirs this is only an experimental drug with potential to harm,” it added.
On the usage of steroids, the DGHS said that steroids are not indicated and are harmful in asymptomatic and mild cases of COVID-19 and should be used in only hospitalised moderately severe and critically ill cases.
The DGHS said that mucormycosis is a fungal disease which occurs in patients with the underlying conditions and predisposing factor such as diabetes mellitus, rampant misuse/overuse of steroids, malignancies, organ transplantation, etc.
“Mode of infection is through inhalation of fungal spores from air. It is not contagious,” it added.
The guidelines also stated on the management of mucormycosis cases which have increased in the second wave of the coronavirus pandemic.